Elektrofi has entered a partnership with ImmunoPrecise Antibodies (IPA) for developing a high-concentration formulation of the latter’s Covid-19 antibody cocktail, PolyTope TATX-03. The alliance intends to produce a data package required for filing an investigational […]
SMi Group reports: ahead of the Pain Therapeutics Conference, SMi Group caught up with Andrea Small-Howard, GB Sciences Inc. SMi Group has worked with the Pain Therapeutics industry for 22 years now which has enabled […]
Moderna has signed a memorandum of understanding (MoU) with the Government of the Republic of Kenya to build a messenger ribonucleic acid (mRNA) manufacturing facility in the country. The MoU was signed by the company […]
Eisai has reported that its therapy Lenvima (lenvatinib mesylate) obtained approval in Taiwan to treat advanced endometrial carcinoma patients along with Merck’s (MSD) Keytruda (pembrolizumab). An orally available inhibitor of multiple receptor tyrosine kinase, Lenvima […]
The European Commission (EC) has granted marketing authorisation to Boehringer Ingelheim and Eli Lilly and Company’s Jardiance (empagliflozin) to treat symptomatic chronic heart failure in adult patients. With the latest development, Jardiance became the first […]